Loading...
Anti-CD3 therapy permits regulatory T cells to surmount T cell receptor–specified peripheral niche constraints
Treatment with anti-CD3 is a promising therapeutic approach for autoimmune diabetes, but its mechanism of action remains unclear. Foxp3(+) regulatory T (T reg) cells may be involved, but the evidence has been conflicting. We investigated this issue in mice derived from the NOD model, which were engi...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The Rockefeller University Press
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2931163/ https://ncbi.nlm.nih.gov/pubmed/20679403 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20100205 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|